Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Hirsch

Showing results (641-650 of 920) with videos related to

Pageof 92
Sort By:
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Design and Synthesis of Novel Bis-Imidazolyl Phenyl Butadiyne Derivatives as HCV NS5A InhibitorsJehad Hamdy, Nouran Emadeldin, Mostafa M Hamed, et al.
Chemical Communications (Cambridge, England)|January 2, 2024
Hit optimization by dynamic combinatorial chemistry on <i>Streptococcus pneumoniae</i> energy-coupling factor transporter ECF-PanTIoulia Antonia Exapicheidou, Atanaz Shams, Hamza Ibrahim, et al.
Transplantation|October 14, 2004
BK virus-associated nephropathy in renal allograft recipients: rescue therapy by sirolimus-based immunosuppressionRavinder K Wali, Cinthia Drachenberg, Hans H Hirsch, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 24, 2025
The Swiss Transplant Cohort Study: Implications for Transplant Infectious Diseases ResearchChristian van Delden, Oriol Manuel, Cédric Hirzel, et al.
Biomacromolecules|July 31, 2023
pH-Responsive Dynaplexes as Potent Apoptosis Inductors by Intracellular Delivery of Survivin siRNAYun Liu, Salma Ashmawy, Lorenz Latta, et al.
European Journal of Medicinal Chemistry|December 27, 2021
Redesigning of the cap conformation and symmetry of the diphenylethyne core to yield highly potent pan-genotypic NS5A inhibitors with high potency and high resistance barrierMennatallah Abdallah, Mostafa M Hamed, Efseveia Frakolaki, et al.
AIDS (London, England)|December 6, 2005
Clinical validation of atazanavir/ritonavir genotypic resistance score in protease inhibitor-experienced patientsSamir Vora, Anne-Geneviève Marcelin, Huldrych F Günthard, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 10, 2012
Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter studyH H Hirsch, F Vincenti, S Friman, et al.
Journal of Virology|June 1, 2012
Differential patterns of large tumor antigen-specific immune responsiveness in patients with BK polyomavirus-positive prostate cancer or benign prostatic hyperplasiaGiovanni Sais, Stephen Wyler, Tvrtko Hudolin, et al.
Medical Microbiology and Immunology|March 24, 2019
Seroprevalence of hepatitis E virus (HEV) in a general adult population in Northern Norway: the Tromsø studyIrene Beate Olsøy, Stian Henriksen, Fabian H Weissbach, et al.
Pageof 92

Showing results (641-650 of 920) with videos related to

Sort By:
Pageof 92
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Design and Synthesis of Novel Bis-Imidazolyl Phenyl Butadiyne Derivatives as HCV NS5A InhibitorsJehad Hamdy, Nouran Emadeldin, Mostafa M Hamed, et al.
Chemical Communications (Cambridge, England)|January 2, 2024
Hit optimization by dynamic combinatorial chemistry on <i>Streptococcus pneumoniae</i> energy-coupling factor transporter ECF-PanTIoulia Antonia Exapicheidou, Atanaz Shams, Hamza Ibrahim, et al.
Transplantation|October 14, 2004
BK virus-associated nephropathy in renal allograft recipients: rescue therapy by sirolimus-based immunosuppressionRavinder K Wali, Cinthia Drachenberg, Hans H Hirsch, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 24, 2025
The Swiss Transplant Cohort Study: Implications for Transplant Infectious Diseases ResearchChristian van Delden, Oriol Manuel, Cédric Hirzel, et al.
Biomacromolecules|July 31, 2023
pH-Responsive Dynaplexes as Potent Apoptosis Inductors by Intracellular Delivery of Survivin siRNAYun Liu, Salma Ashmawy, Lorenz Latta, et al.
European Journal of Medicinal Chemistry|December 27, 2021
Redesigning of the cap conformation and symmetry of the diphenylethyne core to yield highly potent pan-genotypic NS5A inhibitors with high potency and high resistance barrierMennatallah Abdallah, Mostafa M Hamed, Efseveia Frakolaki, et al.
AIDS (London, England)|December 6, 2005
Clinical validation of atazanavir/ritonavir genotypic resistance score in protease inhibitor-experienced patientsSamir Vora, Anne-Geneviève Marcelin, Huldrych F Günthard, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 10, 2012
Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter studyH H Hirsch, F Vincenti, S Friman, et al.
Journal of Virology|June 1, 2012
Differential patterns of large tumor antigen-specific immune responsiveness in patients with BK polyomavirus-positive prostate cancer or benign prostatic hyperplasiaGiovanni Sais, Stephen Wyler, Tvrtko Hudolin, et al.
Medical Microbiology and Immunology|March 24, 2019
Seroprevalence of hepatitis E virus (HEV) in a general adult population in Northern Norway: the Tromsø studyIrene Beate Olsøy, Stian Henriksen, Fabian H Weissbach, et al.
Pageof 92